Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure

Completed · Not applicable

Conditions studied: Mild Cognitive Impairment, Alzheimer Disease, Amnestic Mild Cognitive Disorder

In brief

The proposed project will assess long-term changes to health/lifestyle, advanced planning, and research engagement that Black and White patients with Amnestic Mild Cognitive Impairment (aMCI) make following disclosure of positron emission tomography-based amyloid and tau burden and associated risk of conversion to Dementia-Alzheimer's Type. Healthcare access will be explored as potential barrier to or facilitator of behavior change.

Key facts

Study ID
NCT05584241
Run by
University of Michigan
People needed
102
Starts
2023-02-20
Expected to finish
2026-05-21
Last updated by the study team
2026-07-08

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.